The Royal Women’s Hospital - Centre for Women’s Infectious Diseases Research, University of Tübingen - Institute for Medical Virology and Epidemiology of Viral Diseases, Royal Infirmary of Edinburgh - Scottish HPV Reference Laboratory, Charité - Universitätsmedizin Berlin, Scientific Institute of Public Health - Unit of Cancer Epidemiology, National Institutes of Health, ISGlobal, University of Ljubljana - Institute of Microbiology and Immunology, Karolinska Institutet - Department of Laboratory Medicine, Government of the United States of America - Division of High Consequence Pathogens and Pathology, University of Cambridge - Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of Malaya (UM), All India Institute of Medical Sciences (AIIMS), The University of Hong Kong - Queen Mary Hospital, University of California San Francisco, University of South Florida - Morsani College of Medicine, Australian Centre for the Prevention of Cervical Cancer and Harvard University - Brigham and Women’s Hospital

The Royal Women’s Hospital - Centre for Women’s Infectious Diseases Research, All India Institute of Medical Sciences (AIIMS), University of Malaya (UM), University of Cambridge - Department of Pathology, affiliation not provided to SSRN, University of Melbourne, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida - Morsani College of Medicine, The University of Hong Kong - Queen Mary Hospital, Harvard University - Brigham and Women’s Hospital, National Cancer Institute and Aristotle University of Thessaloniki

City of Hope - Comprehensive Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of California, Los Angeles (UCLA), UCLA Center for Health Policy Research and H. Lee Moffitt Cancer Center and Research Institute